Eugene I. Hwang

Eugene I. Hwang

Pediatrics
111 Michigan Avenue Northwest, Childrens National Telemedicine
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Journal: Nature medicine
Published: July 22, 2026

Transcriptomic Meta-Analysis and Functional Validation Identify Long Non-Coding RNAs as Modulators of Zika Virus-Mediated Oncolysis in Glioblastoma Multiforme Cell Lines.

Transcriptomic Meta-Analysis and Functional Validation Identify Long Non-Coding RNAs as Modulators of Zika Virus-Mediated Oncolysis in Glioblastoma Multiforme Cell Lines.

Journal: Cells
Published: April 27, 2026

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2026

Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional Remodeling.

Acute Myeloid Leukemia Relapse after Bromodomain Inhibitor Treatment or Chemotherapy is Characterized by Myc-Ras Transcriptional Remodeling.

Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025

Challenges in diagnostics and treatment of infant-type hemispheric gliomas.

Challenges in diagnostics and treatment of infant-type hemispheric gliomas.

Journal: Neuro-oncology advances
Published: October 22, 2025

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.

Journal: Nature medicine
Published: October 09, 2025

The T cell receptor landscape of childhood brain tumors.

The T cell receptor landscape of childhood brain tumors.

Journal: Science translational medicine
Published: March 19, 2025

Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation.

Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation.

Journal: Frontiers in oncology
Published: October 01, 2024

Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors.

Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors.

Journal: Expert review of clinical immunology
Published: August 08, 2024

Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies.

Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies.

Journal: JCO precision oncology
Published: July 08, 2024

Cabozantinib in children with recurrent diffuse gliomas.

Cabozantinib in children with recurrent diffuse gliomas.

Journal: Pediatric blood & cancer
Published: May 16, 2024

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 26, 2024
Showing 1-12 of 72

Last Updated: 09/26/2026